Back
Nektar Therapeutics Stock Price Chart

BigBear.ai stock just exploded on AI and big data plays, surging to a $2B valuation.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
NKTR
Nektar Therapeutics
Last Price:
$0.94
Seasonality Move:
-1.1%
7 Day Trial
ALL ACCESS PASS
$
7

10 Stellar Stocks - get the names here
Learn their names here. FREE-
The current trend is relatively stagnant and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
Nektar Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.9 | Buy |
20-day SMA: | 0.84 | Buy |
50-day SMA: | 0.92 | Buy |
200-day SMA: | 1.21 | Sell |
8-day EMA: | 0.92 | Buy |
20-day EMA: | 0.88 | Buy |
50-day EMA: | 0.93 | Sell |
200-day EMA: | 1.09 | Sell |
Nektar Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 53.83 | Buy |
Chaikin Money Flow: | -952258 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.75 - 0.95) | Buy |
Bollinger Bands (100): | (0.88 - 1.28) | Sell |
Nektar Therapeutics Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.93 while NKTR 8-day simple moving average is 0.90, which is a Buy signal.
-
The stock price of NKTR is 0.93 while Nektar Therapeutics 20-day SMA is 0.84, which makes it a Buy.
-
Nektar Therapeutics 50-day simple moving average is 0.92 while NKTR share price is 0.93, making it a Buy technically.
-
NKTR stock price is 0.93 and Nektar Therapeutics 200-day simple moving average is 1.21, creating a Sell signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
36
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a SellThe current Nektar Therapeutics [NKTR] share price is $0.93. The Score for NKTR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
172M
Price in USD:
0.93
Share Volume:
1.2M
Nektar Therapeutics 52-Week Range
52-Week High:
1.93
52-Week Low:
0.63
Sell
36
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 0.93 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.93 while NKTR 8-day exponential moving average is 0.92, which is a Buy signal.
-
The stock price of NKTR is 0.93 while Nektar Therapeutics 20-day EMA is 0.88, which makes it a Buy.
-
Nektar Therapeutics 50-day exponential moving average is 0.93 while NKTR share price is 0.93, making it a Sell technically.
-
NKTR stock price is 0.93 and Nektar Therapeutics 200-day simple moving average is 1.09, creating a Sell signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.02 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Nektar Therapeutics is a Buy
-
Nektar Therapeutics Relative Strength Index (RSI) is 53.83, which suggest Nektar Therapeutics is overbought
-
The Bollinger Bands (25) for Nektar Therapeutics is (0.75 - 0.95), which suggest Nektar Therapeutics is a Sell
-
The Bollinger Bands (100) for Nektar Therapeutics is (0.88 - 1.28), which suggest Nektar Therapeutics is a Sell
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.